Aurelie Gouel-Cheron1, Keith Lumbard2, Sally Hunsberger3, Fernando J Arteaga-Cabello4, John Beigel5, Pablo F Belaunzarán-Zamudio6, Sandra Caballero-Sosa7, Kenia Escobedo-López8, Violeta Ibarra-González9, José Gabriel Nájera-Cancino10, Héctor Armando Rincón-León11, Emilia Ruiz-Hernández12, Jesús Sepúlveda-Delgado13, Karina Trujillo-Murillo14, Guillermo Ruiz-Palacios15. 1. Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, MD, USA; Département d'Anesthésie et Réanimation Chirurgicale, Groupe Hospitalier Bichat Claude Bernard, Université de Paris, Assistance Publique Hôpitaux de Paris, Paris, France; Unit of Antibodies in Therapy and Pathology, Pasteur Institut, UMR 1222 INSERM, Paris, France. Electronic address: aurelie.gouel@aphp.fr. 2. Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, MD, USA. Electronic address: keith.lumbard@nih.gov. 3. Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, MD, USA. Electronic address: sally.hunsberger@nih.gov. 4. Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: ferartc@gmail.com. 5. National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA. Electronic address: jbeigel@niaid.nih.gov. 6. Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: p.belaunz@infecto.mx. 7. Clínica Hospital Dr. Roberto Nettel Flores, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Tapachula, Chiapas, Mexico. Electronic address: sandracaballero@redmexei.mx. 8. Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: kemesk@yahoo.com. 9. Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: violetaig@gotmail.com. 10. Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico. Electronic address: gabriel.najera.78@gmail.com. 11. Unidad de Medicina Familiar No.11, Instituto Mexicano del Seguro Social, Tapachula, Chiapas, Mexico. Electronic address: hector.rinconl@imss.gob.mx. 12. Hospital General de Tapachula, Tapachula, Chiapas, Mexico. Electronic address: dramilieruiz@gmail.com. 13. Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico. Electronic address: jesussd52@gmail.com. 14. Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico. Electronic address: kary_trujillo@hotmail.com. 15. Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: gmrps@unam.mx.
Abstract
BACKGROUND: Real-time RT-PCR (Reverse Transcriptase Polymerase Chain Reaction) is considered the gold standard for Zika virus (ZIKV) infection diagnosis, despite its low sensitivity. Diagnosis using recommended serologic cutoffs in co-circulating Flaviviruses areas maybe inadequate due to in-vitro cross-reactivities of Flaviviruses-specific antibodies. We evaluated Zika diagnosis in symptomatic patients using serial RT-PCR and develop a classification model using serial Dengue virus (DENV) and ZIKV serologies. METHODS: A prospective longitudinal multicentric study in Southern Mexico (NCT02831699) enrolled symptomatic and non-symptomatic participants. In the classification model, true positives were symptomatic (using a modified World Health Organization/Pan American Health Organization definition) with RT-PCR positive for ZIKV or DENV. True negatives were non-symptomatic with negative RT-PCR. Serial serology measurements were used to predict disease status. RESULTS: Analyzing ZIKV and DENV RT-PCR at 3 timepoints between days 3 and 13 of symptom onset detected 25% more cases than a single RT-PCR analysis between day 0 and 6. When considering sensitivity and specificity together, the serial serology model predicted all categories of disease and negatives better than manufactures cutoffs. Their cutoffs optimized sensitivity or specificity but not both. CONCLUSIONS: We demonstrated the importance of serial RT-PCR and antibody measurements to diagnose arbovirus infection in symptomatic patients living in regions with co-circulating flaviviruses.
BACKGROUND: Real-time RT-PCR (Reverse Transcriptase Polymerase Chain Reaction) is considered the gold standard for Zika virus (ZIKV) infection diagnosis, despite its low sensitivity. Diagnosis using recommended serologic cutoffs in co-circulating Flaviviruses areas maybe inadequate due to in-vitro cross-reactivities of Flaviviruses-specific antibodies. We evaluated Zika diagnosis in symptomatic patients using serial RT-PCR and develop a classification model using serial Dengue virus (DENV) and ZIKV serologies. METHODS: A prospective longitudinal multicentric study in Southern Mexico (NCT02831699) enrolled symptomatic and non-symptomatic participants. In the classification model, true positives were symptomatic (using a modified World Health Organization/Pan American Health Organization definition) with RT-PCR positive for ZIKV or DENV. True negatives were non-symptomatic with negative RT-PCR. Serial serology measurements were used to predict disease status. RESULTS: Analyzing ZIKV and DENV RT-PCR at 3 timepoints between days 3 and 13 of symptom onset detected 25% more cases than a single RT-PCR analysis between day 0 and 6. When considering sensitivity and specificity together, the serial serology model predicted all categories of disease and negatives better than manufactures cutoffs. Their cutoffs optimized sensitivity or specificity but not both. CONCLUSIONS: We demonstrated the importance of serial RT-PCR and antibody measurements to diagnose arbovirus infection in symptomatic patients living in regions with co-circulating flaviviruses.
Authors: Pablo F Belaunzarán-Zamudio; Héctor Armando Rincón León; Sandra Caballero Sosa; Emilia Ruiz; José Gabriel Nájera Cancino; Paul Rodriguez de La Rosa; María de Lourdes Guerrero Almeida; John H Powers; John H Beigel; Sally Hunsberger; Karina Trujillo; Pilar Ramos; Fernando J Arteaga-Cabello; Alexander López-Roblero; Raydel Valdés-Salgado; Hugo Arroyo-Figueroa; Eli Becerril; Guillermo Ruiz-Palacios Journal: BMC Infect Dis Date: 2021-08-28 Impact factor: 3.090
Authors: Pablo F Belaunzarán-Zamudio; Allyson Mateja; Paola Del Carmen Guerra-de-Blas; Héctor A Rincón-León; Karla Navarro-Fuentes; Emilia Ruiz-Hernández; Sandra Caballero-Sosa; Francisco Camas-Durán; Zoila Priego-Smith; José G Nájera-Cancino; Alexander López-Roblero; Karina Del Carmen Trujillo-Murillo; John H Powers; Sally Hunsberger; Sophia Siddiqui; John H Beigel; Raydel Valdés-Salgado; Guillermo Ruiz-Palacios Journal: PLoS Negl Trop Dis Date: 2021-02-16
Authors: Sally Hunsberger; Ana M Ortega-Villa; John H Powers; Héctor Armando Rincón León; Sandra Caballero Sosa; Emilia Ruiz Hernández; José Gabriel Nájera Cancino; Martha Nason; Keith Lumbard; Jesús Sepulveda; Paola Del Carmen Guerra de Blas; Guillermo Ruiz-Palacios; Pablo F Belaunzarán-Zamudio Journal: Int J Infect Dis Date: 2020-06-25 Impact factor: 12.074